Clinical Trials in New York

Showing 4441-4460 of 22,668 trials

A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B)

NCT05277571

The purpose of the study is to investigate the safety and tolerability of single-ascending doses of UCB1381 (intravenous and subcutaneous) in healthy study participants and after repeat intravenous dosing in study participants with atopic dermatitis. Efficacy will be assessed following repeat intravenous dosing versus placebo in study participants with atopic dermatitis.

Atopic Dermatitis

UCB Biopharma SRL273 participantsStarted Mar 2022

Beverly Hills, California, United States • Glendale, California, United States • Los Angeles, California, United States +13 more locations

Enrolling By Invitation< 1 mile

Healthcare Integrity & Anti-Fraud Enforcement

NCT07217730

The PHX-AFK-US Protocol is a coalition-backed regulatory scaffold designed to restore healthcare integrity across U.S. facilities. It targets fraud, kickback schemes, and supply chain opacity through validator governance, smart contract enforcement, and public transparency. Anchored by notarized affidavits, NFT fiscal instruments, and dashboard oversight, this protocol empowers whistleblowers, mobilizes validators, and escalates complaints to federal and state regulators. It integrates secure audit trails, DAO voting logic, and asset freeze triggers to ensure accountability, reform, and systemic trust.

Healthcare Fraud SchemesKickback NetworksSupply Chain Vulnerabilities+5 more

Truway Health, Inc.100 participantsStarted Oct 2025

New York, New York, United States

A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B)

Healthcare Integrity & Anti-Fraud Enforcement

Find Trials by Condition in New York

Retro Comparison of Subsidence Following Interbody Devices in Lumbar Spine

A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer

An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer.

Propranolol Treatment for Postoperative Chylothorax

Increasing Long-Term Physical Activity After Lumbar Spine Surgery

A Study of Multiple Doses of Nusinersen (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy

A Study of Sovilnesib in Subjects With Ovarian Cancer

Personalized Therapy Study - HFRS (TriageHF) Post Approval Study

Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)

Deployment and Evaluation of Humanoid Robotics in Coalition-Aligned Clinical Care Settings

GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor

Can Mobilizations Applied to the Thoracic Spine Improve Oxygen Saturation Levels and Thoracic Kyphosis in E-Cigarette Smokers?

A Novel Approach to Upper Extremity Amputation to Augment Volitional Control and Restore Proprioception

Improving Postamputation Functioning by Decreasing Phantom Pain With Perioperative Continuous Peripheral Nerve Blocks: A Department of Defense Funded Multicenter Study

Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)

A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is Tolerated

A Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH3739937 in in Treatment-Naive Adults Living With HIV-1